中文摘要 ii
英文摘要 iii
圖次 vi
表次 viii

第一章 前言 1

第二章 文獻回顧 2
第一節 糖尿病 2
一、糖尿病簡介 2
二、胰島素簡介 2
三、糖尿病分類 3
四、糖尿病診斷方法 5
第二節 肥胖 7
一、肥胖的定義與形成原因 7
二、肥胖流行病學 7
三、脂肪組織 8
四、肥胖與代謝性疾病 10
五、代謝性發炎反應(metaflammation) 11
第三節 NLRP3發炎體 12
一、NOD-like receptor (NLRs) 12
二、NLRP3發炎體結構及活化機制 13
三、NLRP3發炎體與肥胖 16
第四節 硫辛酸 17
一、硫辛酸特性 17
二、硫辛酸與第二型糖尿病 18
三、硫辛酸的治療潛力 19

第三章 研究動機與實驗架構 20
第一節 研究動機 20
第二節 實驗架構 21

第四章 實驗之材料與方法 22
第一節 實驗材料 22
第二節 實驗設備 24
第三節 實驗方法 25

第五章 結果與討論 32
第一節 硫辛酸對第二型糖尿病大鼠生理之影響 32
第二節 硫辛酸對第二型糖尿病大鼠血糖調節功能之影響 38
第三節 硫辛酸對第二型糖尿病大鼠血清脂質之影響 43
第四節 硫辛酸對胰島素訊息傳遞相關蛋白表現量之影響 45
第五節 硫辛酸對NLRP3發炎體訊息傳遞相關蛋白表現量之影響 48

第六章 結語 58

第七章 參考文獻 59

ADA. (2017). Standards of Medical Care in Diabetes -2017(Vol. Volume 40): American Diabetes Association.
Alberti, K. G. M. M., & Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine, 15(7), 539–553.
Bhargava, P., & Lee, C. (2012). Role and function of macrophages in the metabolic syndrome. Biochemical Journal, 442(2), 253–262.
Biewenga, G., Haenen, G., & Bast, A. (1997). The pharmacology of the antioxidant lipoic acid. General Pharmacology: The Vascular System, 29(3), 315–331.
Chen, W., Kang, C., Wang, G., & Lee, H. (2012). Α-lipoic acid regulates lipid metabolism through induction of sirtuin 1 (SIRT1) and activation of aMP-activated protein kinase. Diabetologia, 55(6), 1824–1835.
Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., & Garg, R. (2005). Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation, 111(11), 1448–1454.
De Nardo, D., & Latz, E. (2011). NLRP3 inflammasomes link inflammation and metabolic disease. Trends in Immunology, 32(8), 373–379.
Deiuliis, J., Kampfrath, T., Ying, Z., Maiseyeu, A., & Rajagopalan, S. (2011). Lipoic acid Attenuates innate immune infiltration and activation in the visceral Adipose tissue of obese insulin resistant mice. Lipids, 46(11), 1021–1032.
Dinarello, C. A. (2009). Immunological and inflammatory functions of the Interleukin-1 family. Annual Review of Immunology, 27(1), 519–550.
Doyle, S., Ozaki, E., & Campbell, M. (2015). Targeting the NLRP3 inflammasome in chronic inflammatory diseases: Current perspectives. Journal of Inflammation Research.
Feingold, K., & Grunfeld, C. (1992). Role of Cytokines in inducing Hyperlipidemia. Diabetes, 41(Supplement_2), 97–101.
Fernández-Galilea, M., Prieto-Hontoria, P., Martínez, J., & Moreno-Aliaga, M. (2013). Antiobesity effects of α-lipoic acid supplementation. Clinical Lipidology, 8(3), 371–383.
Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E., & Klein, S. (2007). Visceral fat Adipokine secretion is associated with systemic inflammation in obese humans. Diabetes, 56(4), 1010–1013.
Grant, R., & Dixit, V. (2013). Mechanisms of disease: Inflammasome activation and the development of type 2 diabetes. Frontiers in Immunology, 4-50..
Gregor, M., & Hotamisligil, G. (2011). Inflammatory mechanisms in obesity. Annual Review of Immunology, 29(1), 415–445.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008). Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature Reviews Molecular Cell Biology, 9(5), 367–377.
Guo, H., Callaway, J., & Ting, J. (2015). Inflammasomes: Mechanism of action, role in disease, and therapeutics. Nature Medicine, 21(7), 677–687.
Guo, J., Gao, S., Liu, Z., Zhao, R., & Yang, X. (2016). Alpha-Lipoic acid alleviates acute inflammation and promotes lipid mobilization during the inflammatory response in white Adipose tissue of mice. Lipids, 51(10), 1145–1152.
Gupta, OT., & Gupta, RK. (2015). Visceral Adipose tissue Mesothelial cells: Living on the edge or just taking up space? Trends in Endocrinology & Metabolism, 26(10), 515–523.
Harding, S., Rideout, T., & Jones, P. (2012). Evidence for using Alpha-Lipoic acid in reducing Lipoprotein and inflammatory related Atherosclerotic risk. Journal of Dietary Supplements, 9(2), 116–127.
Hossain, P., Kawar, B., & El Nahas, M. (2007). Obesity and diabetes in the developing world — A growing challenge. New England Journal of Medicine, 356(3), 213–215.
Jager, J., Grémeaux, T., Cormont, M., Le Marchand-Brustel, Y., & Tanti, J. (2007). Interleukin-1β-induced insulin resistance in Adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology, 148(1), 241–251.
Janoudi, A., Shamoun, F., Kalavakunta, J., & Abela, G. (2015). Cholesterol crystal induced arterial inflammation and destabilization of atherosclerotic plaque. European Heart Journal, 37(25), 1959–1967.
Jo, E., Kim, J., Shin, D., & Sasakawa, C. (2015). Molecular mechanisms regulating NLRP3 inflammasome activation. Cellular and Molecular Immunology, 13(2), 148–159.
Kim, Y., Shin, J., & Nahm, M. (2016). NOD-like receptors in infection, immunity, and diseases. Yonsei Medical Journal, 57(1), 5.
Lee, J. (2013). Adipose tissue macrophages in the development of obesity-induced inflammation, insulin resistance and type 2 diabetes. Archives of Pharmacal Research, 36(2), 208–222.
Lee, H., Lee, Y., Chung, Y., Nam, Y., Kim, S., Park, E., Hong, SM., Yang, YK., Kim, HC., & Jeong, J. (2015). Beneficial effects of red yeast rice on high-fat diet-induced obesity, Hyperlipidemia, and fatty liver in mice. Journal of Medicinal Food, 18(10), 1095–1102.
Lee, YS., Li, P., Huh, JY., Hwang, IJ., Lu, M., Kim, JI., Ham, M., Talukdar, S., Chen, A., Lu, WJ., Bandyopadhyay, GK., Schwendener, R., Olefsky, J., & Kim, JB. (2011). Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes, 60(10), 2474–2483.
Legrand-Poels, S., Esser, N., L’homme, L., Scheen, A., Paquot, N., & Piette, J. (2014). Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes. Biochemical Pharmacology, 92(1), 131–141.
Lyons, C., Kennedy, E., & Roche, H. (2016). Metabolic inflammation-differential modulation by dietary constituents. Nutrients, 8(5), 247.
Pradhan, A. (2008). Obesity, metabolic syndrome, and type 2 diabetes: Inflammatory basis of glucose metabolic disorders. Nutrition Reviews, 65, S152–S156.
Reynolds, C., McGillicuddy, F., Harford, K., Finucane, O., Mills, K., & Roche, H. (2012). Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells-implications for diet-induced insulin resistance. Molecular Nutrition & Food Research, 56(8), 1212–1222.
Riedl, S., & Shi, Y. (2004). Molecular mechanisms of caspase regulation during apoptosis. Nature Reviews Molecular Cell Biology, 5(11), 897–907.
Rudich, A., Tirosh, A., Potashnik, R., Khamaisi, M., & Bashan, N. (1999). Lipoic acid protects against oxidative stress induced impairment in insulin stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes. Diabetologia, 42(8), 949–957.
Schroder, K., & Tschopp, J. (2010). The Inflammasomes. Cell, 140(6), 821–832.
Stienstra, R., van Diepen, J., Tack, C., Zaki, M., van de Veerdonk, Fl., Perera, D., Neale, GA., Hooiveld, GJ., Hijmans, A., Vroegrijk, I., van den Berg, S., Romijn, J., Rensen, PC., Joosten, LA., Netea, MG., & Kanneganti, T. (2011). Inflammasome is a central player in the induction of obesity and insulin resistance. Proceedings of the National Academy of Sciences, 108(37), 15324–15329.
Tateya, S., Kim, F., & Tamori, Y. (2013). Recent advances in obesity-induced inflammation and insulin resistance. Frontiers in Endocrinology, 4, . doi:10.3389/fendo.2013.00093
Tilg, H., & Moschen, A. R. (2006). Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology, 6(10), 772–783.
Vandanmagsar, B., Youm, Y., Ravussin, A., Galgani, J., Stadler, K., Mynatt, R., Ravussin, E., Stephens, JM., & Dixit, V. (2011). The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nature Medicine, 17(2), 179–188.
Wang, X., He, G., Peng, Y., Zhong, W., Wang, Y., & Zhang, B. (2015). Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway. Scientific Reports, 5, 12676.
Watanabe, Y., Nagai, Y., & Takatsu, K. (2013). Activation and regulation of the pattern recognition receptors in obesity-induced Adipose tissue inflammation and insulin resistance. Nutrients, 5(9), 3757–3778.
Weber, C., & Noels, H. (2011). Atherosclerosis: Current pathogenesis and therapeutic options. Nature Medicine, 17(11), 1410–1422.
Weber, K., & Schilling, J. D. (2014). Lysosomes integrate metabolic-inflammatory cross-talk in primary Macrophage Inflammasome activation. Journal of Biological Chemistry, 289(13), 9158–9171.
Wright, T. M. (1997). Cytokines in acute and chronic inflammation. Frontiers in Bioscience, 2(4), d12–26.
Yang, R., Shi, Y., Hao, G., Li, W., & Le, G. (2008). Increasing Oxidative stress with progressive Hyperlipidemia in human: Relation between Malondialdehyde and Atherogenic index. Journal of Clinical Biochemistry and Nutrition, 43(3), 154–158.
Yaworsky, K., Somwar, R., Ramlal, T., Tritschler, H., & Klip, A. (2000). Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by α-lipoic acid in 3T3-L1 adipocytes. Diabetologia, 43(3), 294–303.
Ye, J., Gao, Z., Yin, J., & He, Q. (2007). Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. AJP: Endocrinology and Metabolism, 293(4), E1118–E1128.